MEMOPTIC Trial Aims to Preserve Vision in Open-Angle Glaucoma Patients
The trial is investigating the efficacy of MEMOPTIC, a neuroprotective tablet, in preserving vision in patients with chronic open-angle glaucoma.
Asset / Drug
Drug and asset intelligence for MEMOPTIC with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.